Somatic Cell Therapy: A Genetic Rescue for a Tattered Immune System?

BioéthiqueOnline 1:4 (2012)
  Copy   BIBTEX

Abstract

The case of Andrew Gobea, the first child to receive experimental gene therapy for SCID, and a reflection on the associated ethical implications of gene therapy research.

Other Versions

No versions found

Links

PhilArchive

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Genetic Disorders and the Ethical Status of Germ-Line Gene Therapy.E. M. Berger & B. M. Gert - 1991 - Journal of Medicine and Philosophy 16 (6):667-683.
Gene Therapy.Ruth Chadwick - 1998 - In Helga Kuhse & Peter Singer (eds.), A Companion to Bioethics. Malden, Mass., USA: Wiley-Blackwell. pp. 205–215.
Canadian guidelines for research on somatic cell gene therapy in humans (1).Francis S. Rolleston - 1991 - Journal International de Bioethique= International Journal of Bioethics 2 (4):241-244.
Human Gene Therapy.Mary Carrington Coutts - 1994 - Kennedy Institute of Ethics Journal 4 (1):63-83.
Human Gene therapy: Why draw a line?W. French Anderson - 1989 - Journal of Medicine and Philosophy 14 (6):681-693.
Human gene therapy and the slippery slope argument.Veikko Launis - 2002 - Medicine, Health Care and Philosophy 5 (2):169-179.
Human gene therapy and slippery slope arguments.T. McGleenan - 1995 - Journal of Medical Ethics 21 (6):350-355.
Germ-Line Gene Therapy and the Medical Imperative.Ronald Munson & Lawrence H. Davis - 1992 - Kennedy Institute of Ethics Journal 2 (2):137-158.

Analytics

Added to PP
2017-08-24

Downloads
212 (#120,153)

6 months
65 (#89,805)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Bryn Williams-Jones
Université de Montréal

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references